ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer
Fields of Study & Subjects
Cancer
Hypoxia
and Metabolism
Immune cells in cancer
Biochemical Acid Research Studies
Publication details
- Journal / source
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Volume
- 87
- Pages
- 101413–101413
- Publication date
- 7 May 2026
- Language
- EN